ACCC okays Pfizer’s Hospira acquisition

handshake: Medicines australia/Govt letter of agreement
The Australian Competition and Consumer Commission has announced that it will not oppose Pfizer Inc’s proposed $US17 billion acquisition of Hospira Inc. “Pfizer and Hospira are also the two largest suppliers of small molecule drugs in Australia, which are used in hospitals to treat illnesses including cancers, cardiovascular and metabolic diseases, epilepsy, and serious infections,”

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Pharmacist bites man
Next Thunderbirds are go at Priceline Pharmacy